细菌耐药机制指导在抗生素合理应用中的临床价值

详细信息    查看全文 | 推荐本文 |

	英文篇名：Bacterial Resistance Mechanism Guiding the Clinical Value of Rational Application of Antibiotics 作者：李峰 英文作者：LI Feng;The Second People's Hospital of Heze; 关键词：ICU ; 抗生素 ; 耐药性 英文关键词：ICU;;Antibiotic;;Drug resistance 中文刊名：XTYX 英文刊名：Systems Medicine 机构：菏泽市第二人民医院; 出版日期：2018-04-20 出版单位：系统医学 年：2018 期：v.3;No.44 语种：中文; 页：XTYX201808012 页数：3 CN：08 ISSN：10-1369/R 分类号：34-35+41

摘要

目的探讨细菌耐药机制指导在抗生素合理应用中的临床价值。方法选取该院2015年1月—2017年1月ICU收治的使用抗生素的患者,收集菌株814株。对收集的菌株进行药敏试验,对菌株的分布以及耐药情况进行分析统计。结果 814株肺炎克雷伯菌菌株主要分布在痰液(618株,75.92%)、创面分泌物(48株,5.90%)、中段尿(38株,4.66%)、胸腹水(30株,3.69%)中。814株肺炎克雷伯菌产ESBLs226株,非产ESBLs588株,其中ESBLs耐药情况主要以复方新诺明(146株,64.60%)、氨曲南(122株,53.98%)、头孢呋辛(114株,50.44%)、头孢噻肟(110株,48.67%)、头孢吡肟(106株,46.90%)为主;非产ESBLs耐药情况主要以复方新诺明(226株,45.38%)、头孢唑啉(214株,36.39%)、头孢噻肟(194株,32.99%)、头孢呋辛(146株,24.83%)、氨曲南(138株,23.47%)为主。结论细菌耐药情况相对较高,菌株对亚胺培南最为敏感,治疗应当作为首选,对头孢类复合制剂相对敏感,也可作为治疗药物,临床中应当交叉联合用药,避免耐药产生。
        Objective This paper tries to explore the clinical value of antibiotic resistance mechanism guidance in rational use of antibiotics. Methods Patients with antibiotics treated at the ICU from January 2015 to January 2017 were selected and 814 strains were collected. The susceptibility test was conducted on the collected strains, and the distribution and drug resistance of the strains were analyzed and counted. Results 814 strains of Klebsiella pneumoniae were mainly distributed in sputum(618 strains, 75.92%), wound exudate(48 strains, 5.90%), middle urine(38 strains,4.66%), pleural effusion(30 strains, 3.69%). 814 strains of Klebsiella pneumoniae produced 226 strains of ESBLs and558 non-ESBLs strains. Among them, the resistance of ESBLs was mainly compound sulfamethoxazole(146 strains,64.60%), aztreonam(122 strains, 53.98%), cefuroxime( 114 strains, 50.44%), cefotaxime(110 strains, 48.67%) and cefepime(106 strains, 46.90%) were the main strains; non-ESBLs resistant strains were mainly compound sulfamethoxazole(226 strains, 45.38%), cefazolin(214 strains, 36.39%), cefotaxime(194 strains, 32.99%), cefuroxime(146 strains,24.83%), and aztreonam(138 strains, 23.47%) dominated. Conclusion Bacterial drug resistance is relatively high.Strains are most sensitive to imipenem, and treatment should be the first choice. They are relatively sensitive to cephalosporin compound preparations and can also be used as therapeutic drugs. Cross-conjoined drugs should be used in clinical practice to avoid drug resistance.

引文

[1]李春辉,吴安华.MDR、XDR、PDR多重耐药菌暂行标准定义—国际专家建议[J].中国感染控制杂志,2014,13(1):62-64.
    [2]黄勋,邓子德,倪语星,等.多重耐药菌医院感染预防与控制中国专家共识[J].中华医院感染学杂志,2015,14(1):1-9.
    [3]陈奕慧,阮建锋,史兆驹,等.2011-2014年医院感染现患率调查与变化趋势分析[J].中华医院感染学杂志,2016,26(5):1155-1158.
    [4]钱海英.肺炎克雷伯菌产ESBLs和Amp C酶的检测及耐药性分析[J].中华全科医学,2014,12(2):274-275.
    [5]夏梦岩,高全成,袁晨光.大肠埃希菌与肺炎克雷伯菌耐药性的变迁研究[J].中华医院感染学杂志,2014,24(2):287-289.
    [6]胡仁静,严子禾,韩志君,等.感染碳青霉烯耐药的肠杆菌科细菌患者全因死亡的meta分析[J].南京医科大学学报,2016,36(12):1567-1572.
    [7]王颖,巴图德力根.肺炎克雷伯菌的临床分布及耐药性分析[J].内蒙古民族大学学报:自然科学版,2013,28(3):334-336.
    [8]戴仲秋,康梅,马莹,等.四川大学华西医院2006年–2015年肠杆菌科细菌分布及耐药特点分析[J].华西医学,2017,33(3):1-5.
    [9]修连喜,赖善城,林素珍.907株多重耐药菌的分布及临床药师对其药物治疗的干预[J].中国医院用药评价与分析,2018,18(2):270-273.
    [10]谭雪梅.某二甲医院2016年细菌耐药监测结果分析[J].国际检验医学杂志,2018,39(3):369-371.